U.S. flag

An official website of the United States government

NM_000295.5(SERPINA1):c.787del (p.Val263fs) AND Alpha-1-antitrypsin deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 19, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001951534.4

Allele description [Variation Report for NM_000295.5(SERPINA1):c.787del (p.Val263fs)]

NM_000295.5(SERPINA1):c.787del (p.Val263fs)

Gene:
SERPINA1:serpin family A member 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
14q32.13
Genomic location:
Preferred name:
NM_000295.5(SERPINA1):c.787del (p.Val263fs)
HGVS:
  • NC_000014.9:g.94381003del
  • NG_008290.1:g.14692del
  • NM_000295.5:c.787delMANE SELECT
  • NM_001002235.3:c.787del
  • NM_001002236.3:c.787del
  • NM_001127700.2:c.787del
  • NM_001127701.2:c.787del
  • NM_001127702.2:c.787del
  • NM_001127703.2:c.787del
  • NM_001127704.2:c.787del
  • NM_001127705.2:c.787del
  • NM_001127706.2:c.787del
  • NM_001127707.2:c.787del
  • NP_000286.3:p.Val263fs
  • NP_001002235.1:p.Val263fs
  • NP_001002236.1:p.Val263fs
  • NP_001121172.1:p.Val263fs
  • NP_001121173.1:p.Val263fs
  • NP_001121174.1:p.Val263fs
  • NP_001121175.1:p.Val263fs
  • NP_001121176.1:p.Val263fs
  • NP_001121177.1:p.Val263fs
  • NP_001121178.1:p.Val263fs
  • NP_001121179.1:p.Val263fs
  • LRG_575t1:c.787del
  • LRG_575:g.14692del
  • LRG_575p1:p.Val263fs
  • NC_000014.8:g.94847338del
  • NC_000014.8:g.94847340del
Protein change:
V263fs
Links:
dbSNP: rs1200349975
NCBI 1000 Genomes Browser:
rs1200349975
Molecular consequence:
  • NM_000295.5:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001002235.3:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001002236.3:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127700.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127701.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127702.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127703.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127704.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127705.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127706.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127707.2:c.787del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Alpha-1-antitrypsin deficiency (A1ATD)
Synonyms:
AAT deficiency; A1AT deficiency; Alpha1-Antitrypsin Deficiency
Identifiers:
MONDO: MONDO:0013282; MedGen: C0221757; Orphanet: 60; OMIM: 613490

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002244574Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 19, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification and characterisation of eight novel SERPINA1 Null mutations.

Ferrarotti I, Carroll TP, Ottaviani S, Fra AM, O'Brien G, Molloy K, Corda L, Medicina D, Curran DR, McElvaney NG, Luisetti M.

Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.

PubMed [citation]
PMID:
25425243
PMCID:
PMC4255440

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002244574.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

ClinVar contains an entry for this variant (Variation ID: 1460301). This sequence change creates a premature translational stop signal (p.Val263Cysfs*3) in the SERPINA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERPINA1 are known to be pathogenic (PMID: 25425243). This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with emphysema (PMID: 25425243). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024